(Reuters) - Europe's largest drugmaker said an expert committee at the
European Medicines Agency had given a positive opinion on
Cervarix based on data from clinical trials involving the
vaccination of girls and women aged between 10 and 25.
Recommendations for marketing approval by the agency's
Committee for Medicinal Products for Human Use are normally
endorsed by the European Commission within a couple of months.
Read more at Reuters.com Government Filings News
European Medicines Agency had given a positive opinion on
Cervarix based on data from clinical trials involving the
vaccination of girls and women aged between 10 and 25.
Recommendations for marketing approval by the agency's
Committee for Medicinal Products for Human Use are normally
endorsed by the European Commission within a couple of months.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment